Biopool’s Stock Now Trades on OTC Board

Biopool International stock will no longer trade on the Nasdaq’s SmallCap Market because the bid price for its shares has fallen below the $1-per-share Nasdaq minimum requirement.

The company’s stock immediately qualifies to trade on the OTC Bulletin Board under the symbol BIPL.

“The move to the OTC Bulletin Board in no way reflects any adverse financial conditions within the company,” said Michael D. Bick, Biopool chairman and chief executive. “Indeed, we meet and exceed all listing requirements for Nasdaq other than the $1 minimum bid price.”

Ventura-based Biopool develops test kits to assess and diagnose blood disorders, plus specialty chemistry controls used to monitor and measure the presence of drugs. The company’s product line is sold to hospitals, clinical laboratories, commercial reference laboratories and research institutions.